| Closes | Document |
|---|
closed 33 days ago Sep 14, 2026 | Establishment Registration and Product Listing for Tobacco Products Proposed Rule · published Jun 29, 2026 · FDA-2025-N-7130 GMP / manufacturing Tobacco |
closed 36 days ago Sep 11, 2026 | Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign Establishments Proposed Rule · published Jul 13, 2026 · FDA-2025-N-6075 GMP / manufacturing |
closed 82 days ago Jul 27, 2026 | Agency Information Collection Activities; Proposed Collection; Comment Request; Human Drug Compounding Under Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act Notice · published May 26, 2026 · FDA-2026-N-5128 GMP / manufacturing |
closed 89 days ago Jul 20, 2026 | Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements Notice · published Jun 18, 2026 · FDA-2026-N-0686 GMP / manufacturing Food & dietary supplements |
closed 89 days ago Jul 20, 2026 | Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Current Good Manufacturing Practice Regulations for Type A Medicated Articles and Medicated Feeds Notice · published Jun 18, 2026 · FDA-2026-N-0496 GMP / manufacturing |
closed 109 days ago Jun 30, 2026 | List of Bulk Drug Substances for Which There Is a Clinical Need Under Section 503B of the Federal Food, Drug, and Cosmetic Act Notice · published May 1, 2026 · FDA-2018-N-3240 GMP / manufacturing |
closed 117 days ago Jun 22, 2026 | Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Current Good Manufacturing Practice (CGMP): Manufacturing, Processing, Packing, and Holding of Drugs; GMP for Finished Pharmaceuticals (Including Active Pharmaceutical Ingredients) and the Advanced Manufacturing Technologies Designation Program Notice · published May 21, 2026 · FDA-2026-N-0746 GMP / manufacturing |
closed 162 days ago May 8, 2026 | Responding to FDA Form 483 Observations at the Conclusion of a Drug CGMP Inspection: Draft Guidance for Industry; Availability Notice · published Mar 9, 2026 · FDA-2025-D-1504 GMP / manufacturing Vaccines / biologics |
closed 169 days ago May 1, 2026 | List of Bulk Drug Substances for Which There Is a Clinical Need Under Section 503B of the Federal Food, Drug, and Cosmetic Act; Extension of Comment Period Notice · published Jun 26, 2026 · FDA-2018-N-3240, FDA_FRDOC_0001 GMP / manufacturing |
closed 173 days ago Apr 27, 2026 | Agency Information Collection Activities; Proposed Collection; Comment Request; Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements Notice · published Feb 24, 2026 · FDA-2026-N-0686 GMP / manufacturing Food & dietary supplements |
closed 173 days ago Apr 27, 2026 | Agency Information Collection Activities; Proposed Collection; Comment Request; Current Good Manufacturing Practice Regulations for Medicated Feeds Notice · published Feb 25, 2026 · FDA-2026-N-0496 GMP / manufacturing |
closed 179 days ago Apr 21, 2026 | Agency Information Collection Activities; Proposed Collection; Comment Request; Current Good Manufacturing Practice (CGMP): Manufacturing, Processing, Packing, and Holding of Drugs; GMP for Finished Pharmaceuticals (Including Active Pharmaceutical Ingredients) and the Advanced Manufacturing Technologies Designation Program Notice · published Feb 20, 2026 · FDA-2026-N-0746 GMP / manufacturing |
closed 179 days ago Apr 21, 2026 | Agency Information Collection Activities; Proposed Collection; Comment Request; Approved Organizations for Wholesale Drug Distributors and Third-Party Logistics Providers Notice · published Feb 20, 2026 · FDA-2026-N-0684 GMP / manufacturing |